ImmunoSignatures

HealthTell has numerous relationships with major biopharmaceutical firms to facilitate clinical drug development.
HealthTell’s ImmunoSignature libraries provide the capability to monitor a person’s humoral immune response by providing binding events indicative of both active immune system physiology and memory.

ImmunoSignatures are accessible in many sample types and aid in biopharmaceutical trials by: informing patient selection, predicting response to therapeutics and indicating possible adverse events.

Biopharmaceutical firms include HelathTell ImmunoSignature measurements as part of their clinical trial, starting as early as phase I- phase 4. Analysis of samples will be available in days or, as specified by clinical protocols.

Stratified Patients
Identifies Treatment Responders
Indicates Patients with Adverse Events

To learn more about how to partner with HealthTell, contact us!